Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (6): 545-546.DOI: 10.3969/j.issn.1673-8640.2019.06.015
• Orginal Article • Previous Articles Next Articles
Received:2018-07-02
Online:2019-06-30
Published:2019-07-04
CLC Number:
. [J]. Laboratory Medicine, 2019, 34(6): 545-546.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.06.015
| 项目 | 例数 | 百分比（%） |
|---|---|---|
| 液化时间 | ||
| <60 min | 368 | 96.6 |
| ≥60 min | 13 | 3.4 |
| 精液体积 | ||
| <1.5 mL | 27 | 7.1 |
| 1.5~6.8 mL | 352 | 92.4 |
| >6.8 mL | 2 | 0.5 |
| 黏稠度 | ||
| 较稀 | 14 | 3.7 |
| 适中 | 312 | 81.9 |
| 较稠 | 55 | 14.4 |
| pH值 | ||
| <7.2 | 15 | 3.9 |
| 7.2~8.0 | 366 | 96.1 |
| 项目 | 例数 | 百分比（%） |
|---|---|---|
| 液化时间 | ||
| <60 min | 368 | 96.6 |
| ≥60 min | 13 | 3.4 |
| 精液体积 | ||
| <1.5 mL | 27 | 7.1 |
| 1.5~6.8 mL | 352 | 92.4 |
| >6.8 mL | 2 | 0.5 |
| 黏稠度 | ||
| 较稀 | 14 | 3.7 |
| 适中 | 312 | 81.9 |
| 较稠 | 55 | 14.4 |
| pH值 | ||
| <7.2 | 15 | 3.9 |
| 7.2~8.0 | 366 | 96.1 |
| 参数 | 例数 | 百分比（%） |
|---|---|---|
| 总精子密度（×106/mL） | ||
| ≥15 | 368 | 96.6 |
| <15 | 13 | 3.4 |
| 精子总活力（%） | ||
| ≥40 | 292 | 76.6 |
| <40 | 89 | 23.4 |
| 前向运动精子率（%） | ||
| ≥32 | 244 | 64.0 |
| <32 | 137 | 36.0 |
| 形态正常率（%） | ||
| ≥4 | 360 | 94.5 |
| <4 | 21 | 5.5 |
| 精子活力指数（%） | ||
| ≥80 | 237 | 62.2 |
| <80 | 144 | 37.8 |
| 有效精子密度（×106/mL） | ||
| ≥3 | 267 | 70.1 |
| <3 | 114 | 29.9 |
| 参数 | 例数 | 百分比（%） |
|---|---|---|
| 总精子密度（×106/mL） | ||
| ≥15 | 368 | 96.6 |
| <15 | 13 | 3.4 |
| 精子总活力（%） | ||
| ≥40 | 292 | 76.6 |
| <40 | 89 | 23.4 |
| 前向运动精子率（%） | ||
| ≥32 | 244 | 64.0 |
| <32 | 137 | 36.0 |
| 形态正常率（%） | ||
| ≥4 | 360 | 94.5 |
| <4 | 21 | 5.5 |
| 精子活力指数（%） | ||
| ≥80 | 237 | 62.2 |
| <80 | 144 | 37.8 |
| 有效精子密度（×106/mL） | ||
| ≥3 | 267 | 70.1 |
| <3 | 114 | 29.9 |
| [1] | PADUNGTOD C,SAVITZ D A,OVERSTREET J W,et al.Occupational pesticide exposure and semen quality among Chinese workers[J]. J Occup Environ Med,2000,42(10):982-992. |
| [2] | 黄莉萍,李亚斐,熊鸿燕,等. 近25年中国正常男性精液质量的变化趋势分析[J]. 生殖与避孕,2011,31(2):122-128. |
| [3] | 石汉振,陈西,曾冬玉. 广州地区不同检测系统精子浓度和精子活动力参考区间的建立及验证[J]. 检验医学,2018,33(1):10-14. |
| [4] | 童传良,范国华,曹长生,等. 上海地区535例孕前检查正常男性精液质量调查[J]. 中国男科学杂志,2010,24(1):31-34. |
| [5] | 世界卫生组织. 人类精液检查与处理实验室手册[M]. 谷翊群,陈振文,卢文红,等,译. 5版. 北京:人民卫生出版社,2010:10-11. |
| [6] | 尚红,王毓三,申子瑜,等. 全国临床检验操作规程[M]. 4版. 北京:人民卫生出版社,2015:188-193. |
| [7] | GEOFFREY W.WHO laboratory manual for the examination and processing of human semen[M]. 5th ed. Geneva:World Health Organization,2010:15-44. |
| [8] | DEGL'INNOCENTI S,FILIMBERTI E,MAGINI A,et al. Semen cryopreservation for men banking for oligospermia,cancers,and other pathologies:prediction of post-thaw outcome using basal semen quality[J]. Fertil Steril,2013,100(6):1555-1563. e1-3. |
| [9] | JØRGENSEN N,CARLSEN E,NERMOEN I,et al. East-west gradient in semen quality in the Nordic-Baltic area:a study of men from the general population in Denmark,Norway,Estonia and Finland[J]. Hum Reprod,2002,17(8):2199-2208. |
| [10] | SWAN S H,BRAZIL C,DROBNIS E Z,et al.Geographic differences in semen quality of fertile U. S. males[J]. Environ Health Perspect,2003,111(4):414-420. |
| [11] | 杜莉,秦敏,李芬,等. 上海市静安区1 016例孕前检查结果分析[J]. 中国妇幼健康研究,2010,21(5):618-620. |
| [12] | 肖宇,黄永刚,黄朝霞,等. 不育门诊男性精液质量及影响因素研究[J]. 浙江预防医学,2014,26(2):114-118. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
